You are here

  • Home
  • Archive
  • Volume 4, Issue Suppl 1
  • IS LONG-TERM LOW-MOLECULAR-WEIGHT HEPARIN STILL ACCEPTABLE TO PALLIATIVE CARE PATIENTS IN THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS? A QUALITATIVE STUDY REVISITED

Article info

Article menu

Download PDFPDF

Poster presentations
Clinical Supportive and Palliative Care
P 028
IS LONG-TERM LOW-MOLECULAR-WEIGHT HEPARIN STILL ACCEPTABLE TO PALLIATIVE CARE PATIENTS IN THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS? A QUALITATIVE STUDY REVISITED
Free

Authors

    Citation

    Seaman S, Nelson A, Noble S
    IS LONG-TERM LOW-MOLECULAR-WEIGHT HEPARIN STILL ACCEPTABLE TO PALLIATIVE CARE PATIENTS IN THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS? A QUALITATIVE STUDY REVISITED
    BMJ Supportive & Palliative Care 2014;4:A25.

    Publication history

    • First published March 1, 2014.
    Online issue publication 
    April 19, 2016

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions